[PLX] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -348.95%
YoY- 46.40%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 11,320 19,495 10,790 10,967 21,646 17,759 14,248 -14.20%
PBT -5,475 397 -4,437 -4,150 1,667 291 -3,560 33.20%
Tax 2,207 -212 118 38 203 180 34 1511.06%
NP -5,475 397 -4,437 -4,150 1,667 291 -3,560 33.20%
Tax Rate - 53.40% - - -12.18% -61.86% - -
Total Cost 16,795 19,098 15,227 15,117 19,979 17,468 17,808 -3.82%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -48.37 2.04 -41.12 -37.84 7.70 1.64 -24.99 55.25%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.14 0.01 -0.14 -0.13 0.10 0.02 -0.24 -30.16%
EPS Diluted -0.14 0.01 -0.14 -0.13 0.10 0.02 -0.24 -30.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.